News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hydra Biosciences, Inc. Raises $34M in Venture Capital



3/14/2008 12:15:34 PM

Hydra Biosciences Inc., a Cambridge biotech company, confirmed reports it raised $34 million in its third round of venture capital, led by Advanced Technology Ventures. To date, the company has raised $63 million in funding from several investors, including Biogen Idec New Ventures, Lilly Ventures, and Polaris Venture Partners.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES